Cross‐talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis

Author:

Ren Chuanfu1ORCID,Yang Zhi2,Xu En2,Kang Xing2,Wang Xingzhou2,Sun Qi3,Wang Chao2,Zhang Liang1,Miao Ji2,Luo Banxin4,Chen Kai2,Liu Song2,Shen Xiaofei2,Lu Xiaofeng2,Yin Kai56,Wang Meng2,Xia Xuefeng125,Guan Wenxian125

Affiliation:

1. Department of General Surgery Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing Medical University Nanjing China

2. Department of General Surgery Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing China

3. Department of Pathology Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing China

4. Department of General Surgery Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing University of Chinese Medicine Nanjing China

5. Department of General Surgery Taikang Xianlin Drum Tower Hospital Nanjing China

6. Department of General Surgery Taixing Hospital Affiliated to Yangzhou University Taixing China

Abstract

AbstractIn gastric cancer (GC), the liver is a common organ for distant metastasis, and patients with gastric cancer with liver metastasis (GCLM) generally have poor prognosis. The mechanism of GCLM is unclear. Invadopodia are special membrane protrusions formed by tumor cells that can degrade the basement membrane and ECM. Herein, we investigated the role of invadopodia in GCLM. We found that the levels of invadopodia‐associated proteins were significantly higher in liver metastasis than in the primary tumors of patients with GCLM. Furthermore, GC cells could activate hepatic stellate cells (HSCs) within the tumor microenvironment of liver metastases through the secretion of platelet‐derived growth factor subunit B (PDGFB). Activated HSCs secreted hepatocyte growth factor (HGF), which activated the MET proto‐oncogene, MET receptor of GC cells, thereby promoting invadopodia formation through the PI3K/AKT pathway and subsequently enhancing the invasion and metastasis of GC cells. Therefore, cross‐talk between GC cells and HSCs by PDGFB/platelet derived growth factor receptor beta (PDGFRβ) and the HGF/MET axis might represent potential therapeutic targets to treat GCLM.

Funder

Clinical Special Fund of Jiangsu Province

Key Project of Science and Technology Development of Nanjing Medicine

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3